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Summary. Traditionally, the measurement of postvoid 
residual urinary volume (PVR) has played a prominent 
role in the evaluation of men with symptoms uggestive 
of benign prostatic hyperplasia (BPH). This article re- 
views current opinions about the cause of PVR, methods 
and accuracy of measurement, correlations between PVR 
and symptoms as well as physiologic measures of BPH 
and the role of PVR determination i the evaluation of 
BPH patients. Community-based data obtained on PVR in 
men aged between 55 and 74 years in the city of Rotter- 
dam (The Netherlands are reported. 
The International Continence Society Committee on Stan- 
dardization of Terminology [3] defines residual urine as 
the volume of fluid remaining in the bladder immediately 
following the completion of micturition. The committee 
emphasizes that unrepresentative results may be obtained 
when voiding has to occur in unfamiliar surroundings or 
on command with a partially filled or overfilled bladder. 
The interval between voiding and residual urinary volume 
measurement has to be recorded, although there should 
ideally be no interval at all. This is particularly important 
if the patient is in a diuretic phase. 
Traditionally, the measurement of postvoid residual 
urinary volume (PVR) has been an important est in the 
evaluation and follow-up of patients with benign prostatic 
hyperplasia (BPH). Presently, there is no agreement as to 
the place and value of PVR measurement in the diagnos- 
tic evaluation of BPH patients. During the "Second Inter- 
national Consultation on Benign Prostatic Hyperplasia," a 
consensus committee has formulated recommendations 
concerning the diagnostic workup of patients presenting 
with symptoms uggestive of prostatism. Tests were clas- 
sified as mandatory, recommended, or optional. This com- 
mittee recommended the measurement of PVR in the di- 
agnostic workup of patients with symptoms of prostatism 
[10]. Clinical practice guidelines for the United States 
have been issued by the Benign Prostatic Hyperplasia 
Guideline Panel. This panel considered the measurement 
of PVR to be an optional test [6]. 
The cause of PVR 
Residual urine is related to bladder-outflow obstruction. 
Other causes of incomplete mptying include neurogenic 
dysfunction of the lower urinary tract and detrusor failure 
due to pharmacologic causes, overdistension of the bladder 
not related to outflow obstruction, and idiopathic ases. 
A given bladder with a certain premicturition volume 
has a well-defined myogenic apability to generate power. 
This mechanical power of the bladder contraction shows 
itself by yielding a given flow rate in combination with a 
certain detrusor pressure. There is a trade-off between 
flow rate and detrusor pressure; in the case of infravesical 
obstruction, the voiding pressure increases while the flow 
rate decreases [12]. The amount of work needed for the 
bladder to empty completely is determined by the voiding 
pressure and the bladder volume [21]. The amount of en- 
ergy that a certain bladder can generate is limited. 
In animal experiments, Levin et al [17] have shown the 
biphasic nature of the bladder contraction: an initial pha- 
sic contractile response, which determines the pressure re- 
sponse, is followed by a plateau phase that determines the 
ability to empty. The initial phasic response appears to be 
related to the intracellular adenosine triphosphate (ATP) 
concentration, whereas the ability to sustain a contraction 
may be linked to active mitochondrial respiration. Outlet 
obstruction has been shown to cause a marked increase in 
anaerobic metabolism in the rabbit bladder [16]. Malko- 
wicz et al. [18] have shown in the whole-rabbit-bladder 
model of obstruction that the ability of the bladder to 
empty is impaired to a greater degree than is its ability to 
generate pressure. If the bladder uns out of energy before 
it is empty, the detrusor contraction fades away prema- 
turely and a certain amount of residual urine is the conse- 
quence of this decompensation. 
Measurement of PVR: methods and reproducibility 
PVR measurement can he performed by several methods. 
In-and-out catherization has been considered to be the 
most accurate technique. However, Stoller and Millard 
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[23] have shown that the bladder was actually not empty 
in 26% of patients catheterized by urological nurses. Even 
after further instructions to improve the technique, the 
bladder was not empty in 14% of the patients. 
The noninvasive measurement by transabdominal u - 
trasound is presently the method preferred by most urolo- 
gists and their patients. Birch et al. [7] compared five dif- 
ferent formulae that can be used to calculate PVR on the 
basis of measurements made by ultrasound. They con- 
cluded that the concordance between the methods was 
93.6% and, consequently, that there was little to choose 
between. Roehrborn and Peters [20] used a further for- 
mula for volume calculation; volumes determined using 
the ellipsoid formula (0.52 x width x height x length) 
showed an excellent correlation with those measured by 
catheterization (r = 0.982; P < 0.001). These authors also 
noted that the error rate was highest in the low-volume 
range but that the absolute difference between actual and 
estimated PVR values was always low. 
Some clinicians [6] doubt the value of PVR measure- 
ments because of the lack of reproducibility of this test. 
Physiologic measures always exhibit some degree of in- 
traindividual variation. In humans there is no fixed heart 
rate or blood pressure, and it would indeed be very "un- 
physiologic" if there were no variation in PVR. Birch et 
al. [7] reported that of 30 men, 66% had significant varia- 
tions in PVR when 3 scans were done on the same day; 
however, in only 8% of the men were all 3 measurements 
statistically significantly different. All patients in this 
study had residual urinary volumes on all scans, which 
shows that this population was a very selected one. Fur- 
thermore, the authors do not clearly state whether scans 
were done immediately after voiding but mention that 
"further scans were timed at 09.00, 13.00 and 16.30 hrs. 
[sic] or as near to those times as possible." Bruskewitz et 
al. [9] found similar variations in PVR measurements in 
47 men prior to prostatectomy. These authors mention 
neither the method of residual urinary volume determina- 
tion, the interval between the termination of voiding and 
the PVR measurements, nor the length of the period over 
which the measurements were performed. Further and 
better designed studies 0n the variability of PVR mea- 
surement are certainly needed since the two above-men- 
tioned studies are inconclusive for methodologic reasons. 
Which PVR value is normal or abnormal? 
Hinman and Cox [13] recognize that there is always some 
residual urine after voiding (wetness of the bladder mu- 
cosa); they studied four normal men to determine the min- 
imal possible amount of  residual urine. In these men the 
mean minimal volume of residual urine was 0.53 ml 
(range, 0.09-2.34 ml). Di Mare et al. [11] have shown that 
78% of normal men have residual urinary volumes of < 5 
ml and that 100% have a PVR value of  < 12 ml. 
In Rotterdam (The Netherlands), community-based data 
on PVR and symptoms of BPH were collected in a side- 
study of a randomized pilot study on the value of screen- 
ing versus no screening for prostate cancer [8]. Only men 
in whom prostate cancer had been excluded by appropri- 
Table 1. Mean and median values and interquartile ranges ob- 
tained for PVR in four consecutive 5-year age intervals in a com- 
munity-based population of men without prostate cancer or a his- 
tory of prostate operation 
Age Number PVR (ml) 
(years) of men 
Mean + SE Median Interquartile 
range 
55-59 76 22 (+5) 0 0-17 
60-64 100 17 (+5) 0 0-0 
65-69 90 25 (_+5) 0 0-35 
70-74 60 31 (+7) 0 0-53 
Total 326 23 (+3) 0 0-21 
Table 2. Percentage ofmen with a PVR value of less than or equal 
to 50 ml and percentage of men with a value ranging between 50 
and 100 ml as determined by age in a community-based population 
of men without prostate cancer or a history of prostate operation 
Age (years) n % With PVR % With PVR 
_< 50 ml 50-100 ml 
55-59 76 88% 1% 
60-64 100 88% 5% 
65-69 90 82% 12% 
70-74 60 70% 20% 
Total 326 83 % 9% 
ate screening tests and who had not previously undergone 
a prostate operation were included in this side study. The 
374 consecutive men enrolled were part of the commu- 
nity-based population of men aged 55-74 years who had 
been randomly assigned to undergo tests to screen for 
prostate cancer. These men were not specifically asked to 
come to the clinic with a full bladder but were instructed 
to wait for the flowmetry (using a Dantec Urodyn 1000 
flowmeter) and not to void before that time. 
Within 10 min of the termination of voiding, the PVR 
value (expressed in milliliters) was computed using an 
Aloka machine with a 3.5-MHz hand-held probe using the 
formula ~/6 × (width) x (height) x (depth). The 374 men 
in whom a PVR determination was planned were asked to 
void in the flowmeter, but 48 (13%) could not do so at that 
particular point in time. The determination of residual 
urine by ultrasound was performed only in those men who 
could void in the flowmeter (n = 326). Symptoms of pro- 
statism were assessed using the American Urologic Asso- 
ciation (AUA)-7 symptom index [4]. Table 1 shows the 
mean and median values and interquartile ranges obtained 
for PVR in four consecutive 5-year age intervals (range, 
55-74 years). The increase in mean residual urinary vol- 
ume with age was statistically significant (P = 0.02). 
The percentages of men with a PVR value of < 50 ml 
and of 50-100 ml as determined in the different age inter- 
vals is shown in Table 2. The percentage of men with a 
PVR value of > 50 ml shows a statistically significant in- 
crease with age (P = 0.01). 
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Correlations with symptoms 
and other physiologic measures 
Of the 326 evaluable men in the Rotterdam study, 55 had a 
residual urinary volume of > 50 ml. However, in response 
to the AUA-7 question, "Over the past month, how often 
have you had a sensation of not emptying your bladder 
completely after you finished urinating?", 31 (56%) of these 
men answered "never" and only 11 men (20%) responded 
that this was the case "about half the time or more often." 
On the other hand, of the 271 men with a PVR value of 
< 50 ml, 14 (5%) answered "more than half the time or 
always." The score on the above-mentioned AUA-7 ques- 
tion about incomplete mptying was weakly correlated with 
PVR (r -- 0.14, P = 0.01). In this community-based popu- 
lation, weak correlations were also found between PVR 
and the total AUA symptom score (r = 0.25, P < 0.05), 
maximal flow rate (r = -0.18; P 0.05), prostate volume 
(r = 0.21, P < 0.05), and age (r = 0.12; P < 0.05), respec- 
tively. In a group of men included in the BPH treatment- 
outcome pilot study (BTOPS), equally poor correlations 
were found between baseline PVR values and the AUA 
symptom score (r = 0.01; P = 0.84), peak flow rate (r = 
-0.19; P = 0.009), average flow rate (r = -0.19; P = 0.009), 
and prostate size (r = 0.07; P = 0.35), respectively [5]. 
PVR in classification of BPH 
and associated urodynamic findings 
In the past, patients presented more often with the severe 
life-threatening manifestations of BPH. Since these com- 
plications were often related to retention with upper-tract 
dilatation and renal failure, it is not surprising that re- 
sidual urine gained much emphasis in attempts to clas- 
sify BPH according to different grades of severity [22]. 
Presently, patients rarely exhibit these severe complica- 
tions and treatment aims at improvement of the quality of 
life and at prevention of lower-urinary-tract deterioration. 
Many men request evaluation and treatment of sympto- 
matic BPH in the absence of residual urine. Although 
Jones and George [15] have postulated that hydronephro- 
sis occurs only in a significant number of patients with so- 
called high-pressure chronic retention due to reduced 
bladder compliance during the filling phase, it is actually 
unknown as to which and how many men would progress 
to upper-tract dilatation and renal failure. 
PVR as an indication for treatment 
and as a predictor of treatment outcome 
Large studies of the urodynamic results of operative treat- 
ment for BPH have shown that the volume of residual 
urine significantly decreases after the operation. Abrams 
et al. [2] showed in a series of 152 men treated by 
transurethral resection of the prostate that the mean PVR 
value decreased from 106 to 28 ml. Neal et al. [19] re- 
ported a decrease from an average of 196 ml to 67 ml in a 
series of 207 patients. Residual urinary volume was not 
among the factors that seemed to predict for a poor or 
good outcome after the operation in these two studies. 
Jensen et al. [14] studied the outcome of surgery in 120 
men with prostatism. They found that after pressure-flow 
studies, PVR was the second best predictor of outcome, 
although none of the patients who failed could be pre- 
dicted by preoperatively determined parameters. 
Since the outcome does not seem to be influenced by 
the preoperative presence or absence of PVR, it is difficult 
to accept he presence of PVR as an indication for treat- 
ment. The presence of PVR has traditionally been thought 
to be associated with an increased risk for urinary tract in- 
fection. Bruskewitz et al. [9] could not find an association 
between PVR and a history of urinary tract infection in a 
limited group of 47 patients. These authors also con- 
cluded that there was no correlation between the preoper- 
ative PVR value and the postoperative outcome. How- 
ever, it should be noted that only 9 of the 47 patients eval- 
uated in this study had PVR values exceeding 50 ml at all 
measurements; furthermore, of these 9 patients, only 4 
had PVR values exceeding 100 ml at all measurements. 
This indicates that this patient population was most prob- 
ably too small and that the range of the variable of inter- 
est was too restricted to justify these conclusions. Abrams 
et al. [1] have shown that patients with a significant 
amount of residual urine who have low bladder pressures 
at cystometric apacity and during voiding have a poor 
prognosis with regard to normalization of micturition. 
The most relevant finding from a clinical point of view 
is not the exact volume but the presence or absence of a 
significant amount of residual urine. A lack of postvoid 
residual urine is a finding of clinical significance because 
it indicates that the patient can efficiently empty his blad- 
der, although it does not exclude bladder-outflow obstruc- 
tion [3]. The presence of residual urine may be of clinical 
significance for at least two reasons: first, the risk of uri- 
nary tract infection may be increased, although further 
studies are needed to establish this relationship firmly, and 
second, a significant amount of residual urine decreases 
the functional bladder capacity, which may lead to symp- 
toms of frequency, urgency, and nocturia. In cases of very 
high residual urinary volume, overflow incontinence can 
occur. Community-based data indicate that significant 
amounts of residual urine (> 50 ml) occur in < 18% of 
men aged between 55 and 69 years. 
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